VTGN
Vistagen Therapeutics, Inc.
Recent 8-K filings for VTGN
Each filing is summarized by an LLM — headline, three bullets, event type. The source document on EDGAR is one click away. See methodology.
-
May 12, 2026 11:44 UTC other_material item 8.01item 9.01
Vistagen reports positive preliminary OLE data for fasedienol in SAD; well-tolerated up to 12 months
source · VTGN on sec.gov